Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

ResMed35 enrolled

Overview

The purpose of this study is to evaluate an approved, portable device for assessing Sleep Disordered Breathing in Congestive Heart Failure.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Heart Failure, Congestive Sleep Apnea Syndromes

Interventions

ApneaLinkDEVICE

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Moderate to severe heart failure (as determined via Echocardiogram or treating physician) Exclusion Criteria: * Clinically significant asthma requiring therapy * Significant (parenchymal) lung disease * Severe pulmonary hypertension * Hypercapnia (PCO2 \> 60mmHg) * Cardiogenic Shock * Severe chronic renal failure * Narcotic abuse/intravenous drug use (including heart failure due to alcohol abuse or chemotherapy, HIV+ and Hepatitis C) * Methicillin- resistant Staphylococcus aureus infection * Tracheotomy * Enrolled in any concurrent study that may confound the results of this study * Nocturnal positive airway pressure or oxygen * Inability or refusal to sign patient consent form * Inability or refusal to adhere to protocol requirements

Locations (1)

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Outcomes

Primary Outcomes

Apnea- Hypopnea Index

Time frame: Overnight

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.